Advertisement
ResearchIn-Press PreviewImmunology Free access | 10.1172/JCI128895
Find articles by Neo, S. in: JCI | PubMed | Google Scholar
Find articles by Yang, Y. in: JCI | PubMed | Google Scholar
Find articles by
Julien, R.
in:
JCI
|
PubMed
|
Google Scholar
|
Find articles by Ma, R. in: JCI | PubMed | Google Scholar
Find articles by Chen, X. in: JCI | PubMed | Google Scholar
Find articles by Chen, Z. in: JCI | PubMed | Google Scholar
Find articles by Tobin, N. in: JCI | PubMed | Google Scholar
Find articles by
Blake, E.
in:
JCI
|
PubMed
|
Google Scholar
|
Find articles by Seitz, C. in: JCI | PubMed | Google Scholar
Find articles by Thomas, R. in: JCI | PubMed | Google Scholar
Find articles by Wagner, A. in: JCI | PubMed | Google Scholar
Find articles by Andersson, J. in: JCI | PubMed | Google Scholar
Find articles by
de Boniface, J.
in:
JCI
|
PubMed
|
Google Scholar
|
Find articles by Bergh, J. in: JCI | PubMed | Google Scholar
Find articles by Murray, S. in: JCI | PubMed | Google Scholar
Find articles by Alici, E. in: JCI | PubMed | Google Scholar
Find articles by Childs, R. in: JCI | PubMed | Google Scholar
Find articles by Johansson, M. in: JCI | PubMed | Google Scholar
Find articles by Westerberg, L. in: JCI | PubMed | Google Scholar
Find articles by
Haglund, F.
in:
JCI
|
PubMed
|
Google Scholar
|
Find articles by
Hartman, J.
in:
JCI
|
PubMed
|
Google Scholar
|
Find articles by Lundqvist, A. in: JCI | PubMed | Google Scholar
First published November 26, 2019 - More info
High levels of ecto-5'-nucleotidase (CD73) have been implicated in immune suppression and tumor progression, and have also been observed in cancer patients who progress on anti-PD-1 immunotherapy. While regulatory T cells can express CD73 and inhibit T cell responses via the production of adenosine, less is known about CD73 expression in other immune cell populations. We found that tumor-infiltrating NK cells upregulate CD73 expression and the frequency of these CD73+ NK cells correlated with larger tumor size in breast cancer patients. In addition, the expression of multiple alternative immune checkpoint receptors including LAG-3, VISTA, PD-1, and PD-L1 was significantly higher in CD73 positive NK cells than in CD73 negative NK cells. Mechanistically, NK cells transport CD73 in intracellular vesicles to the cell surface and the extracellular space via actin polymerization-dependent exocytosis upon engagement of 4-1BBL on tumor cells. These CD73 positive NK cells undergo transcriptional reprogramming and upregulate IL10 production via STAT3 transcriptional activity, suppressing CD4 T cell proliferation and IFN-ɣ production. Taken together, our results support that tumors can hijack NK cells as a means to escape immunity and that CD73 expression defines an inducible population of NK cells with immune regulatory properties within the tumor microenvironment.